A structural model of 20S immunoproteasomes: effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms. (Q48588098)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2006

Language	Label	Description	Also known as
English	A structural model of 20S immunoproteasomes: effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms.	scientific article published in April 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

A structural model of 20S immunoproteasomes: effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

Aurelia Santoro

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

Bertrand Friguet

10

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

Claudio Franceschi

13

object named as

Claudio Franceschi

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

author name string

Elena Bellavista

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

Richard Sessions

4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

Kathrin Textoris-Taube

5

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

Fabrizio Dal Piaz

6

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

Geraldine Carrard

7

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

Katia Forti

8

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

Stefano Salvioli

9

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

Peter M Kloetzel

11

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

A Jennifer Rivett

12

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

387

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

417-429

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

Proteasome-mediated degradation of tau proteins occurs independently of the chymotrypsin-like activity by a nonprocessive pathway

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Impairment of proteasome structure and function in aging.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Interaction of Hsp90 with 20S proteasome: thermodynamic and kinetic characterization

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Essential role of human leukocyte antigen-encoded proteasome subunits in NF-kappaB activation and prevention of tumor necrosis factor-alpha-induced apoptosis

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Protein-protein interactions among human 20S proteasome subunits and proteassemblin

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Binding of hydrophobic peptides to several non-catalytic sites promotes peptide hydrolysis by all active sites of 20 S proteasomes. Evidence for peptide-induced channel opening in the alpha-rings

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Antigen processing by the proteasome

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

A mathematical model of protein degradation by the proteasome

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Polymorphism in the LMP2 gene influences susceptibility to extraspinal disease in HLA-B27 positive individuals with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Age dependent impact of LMP polymorphisms on TNFalpha-induced apoptosis in human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Immunoproteasomes and immunosenescence

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Proteasome function in antigen presentation: immunoproteasome complexes, Peptide production, and interactions with viral proteins

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Degradation of cell proteins and the generation of MHC class I-presented peptides

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

The structure of the mammalian 20S proteasome at 2.75 A resolution

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Altered peptidase and viral-specific T cell response in LMP2 mutant mice.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Association study of LMP gene polymorphisms in Mexican patients with spondyloarthritis

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

The 26S proteasome: a molecular machine designed for controlled proteolysis

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

IL-1beta, IFN-gamma and TNF-alpha increase vulnerability of pancreatic beta cells to autoimmune destruction

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Fibroblast cultures from healthy centenarians have an active proteasome

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Evidence for the existence of a non-catalytic modifier site of peptide hydrolysis by the 20 S proteasome

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.056

21 January 2018

Identifiers

10.1515/BC.2006.056

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

release_54m75iojh5gpdi7e5wsztwisni

1 reference

https://api.fatcat.wiki/v0/release/54m75iojh5gpdi7e5wsztwisni

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16606340

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48588098&oldid=1843046275"